A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

Biogen Inc. is now projecting a better-than-expected 2024 as the company continues to see an uptick in sales from Leqembi, ...

Biogen experienced challenges in its stock ... of the author and do not necessarily reflect those of Nasdaq, Inc. With headquarters in the heart of Chicago's financial district, Barchart has ...

at 13:29 Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc.

There is clear agreement in the scientific community that magnesium is crucial to human health, supporting everything from bone and heart health to sleep quality and muscle recovery. Yet many studies, ...

This has included the termination of collaborations with Biogen (Nasdaq: BIIB), Sanofi (Euronext: SAN), and Novartis (NOVN: VX). Last year, the firm closed its California headquarters and reduced its ...

and Biogen, as well as each company's remote, part-time, freelance, and flexible job posting history, a staff-written description, and the company's headquarters and website. Verizon is an ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Biogen Inc. raised its annual earnings guidance after reporting better-than-expected third-quarter sales and profit, driven ...